LexDanaLexDanabeta
Inventor

Edward T. Maggio

Inventor
San Diego, CA, US

Overview

46→
Patents
1980–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 46 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
G01NInvestigating or analysing materials by determining their chemical or physical properties12%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests11%
C07KPeptides3%
Y02ATechnologies for adaptation to climate change3%
C07JSteroids2%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data2%
Y10TTechnical subjects covered by former us classification2%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
PatentTitleYear
10,682,414Intranasal epinephrine formulations and methods for the treatment of disease202010,576,156Compositions for drug administration202010,512,694Compositions for oral drug administration201910,265,402Absorption enhancers for drug administration201910,046,025Stabilizing alkylglycoside compositions and methods thereof20189,895,444'Compositions for drug administration'20189,763,876'Administration of benzodiazepine compositions'20179,642,913'Pharmaceutical composition including alkyl glycoside and an anti-seizure agent'20179,446,134'Stabilizing alkylglycoside compositions and methods thereof'20169,283,280'Compositions for drug administration'20169,114,069'Antibacterial compositions for drug administration'20158,927,497'Absorption enhancers for intranasal administration'20158,895,546'Administration of benzodiazepine compositions'20148,883,728'Intranasal administration of active agents to the central nervous system'20148,846,044'Stabilizing alkylglycoside compositions and methods thereof'20148,772,231'Stabilizing alkylglycoside compositions and methods thereof'20148,642,564'Compositions for drug administration'20148,616,377'Device and method for single stream recycling of hazardous materials'20138,613,867'Inorganic dry compositions for absorption of mercury vapor'20138,551,468'Absorption enhancers for intranasal interferon administration'20138,530,463'Multimodal particulate formulations'20138,470,370'Controlled release formulations'20138,440,631'Compositions for drug administration'20138,329,220'Controlled release formulations'20128,268,791'Alkylglycoside compositions for drug administration'20128,226,949'Stabilizing alkylglycoside compositions and methods thereof'20128,173,594'Stabilizing alkylglycoside compositions and methods thereof'20128,133,863'Stabilizing alkylglycoside compositions and methods thereof'20128,084,022'Stabilizing alkylglycoside compositions and methods thereof'20118,076,290'Stabilizing alkylglycoside compositions and methods thereof'20118,068,993'Diagnosing inapparent diseases from common clinical tests using Bayesian analysis'20117,998,927'Stabilizing alkylglycoside compositions and methods thereof'20117,425,542'Stabilizing alkylglycoside compositions and methods thereof'20087,392,199'Diagnosing inapparent diseases from common clinical tests using Bayesian analysis'20085,079,142'Orthogonal flow immunoassays and devices'19924,859,610'Immunoassay incubation device'19894,828,981'Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents'19894,789,631'Immunoassay for anti-dirofilaria immitis antibody'19884,786,471'Heterogeneous immunoassay method and assembly'19884,397,956'Means for monitoring the status of control of ketoacidosis-prone diabetics'19834,385,126'Double tagged immunoassay'19834,277,437'Kit for carrying out chemically induced fluorescence immunoassay'19814,233,401'Antienzyme homogeneous competitive binding assay'19804,233,402'Reagents and method employing channeling'19804,220,450'Chemically induced fluorescence immunoassay'19804,208,479'Label modified immunoassays'1980

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1980–1983Based in Redwood City, CA, US· patent location history
1983–2015Patents assigned to MAGGIO EDWARD T (21)· patent assignee history
1983–2020Based in San Diego, CA, US· patent location history
1988–1992Patents assigned to SYNBIOTICS CORP (4)· patent assignee history
2008–2018Patents assigned to AEGIS THERAPEUTICS INC (3)· patent assignee history
2011–2020Patents assigned to AEGIS THERAPEUTICS LLC (26)· patent assignee history
2013–2017Patents assigned to HALE BIOPHARMA VENTURES LLC (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AEGIS THERAPEUTICS LLC262011–2020
MAGGIO EDWARD Tself211983–2015
SYNBIOTICS CORP41988–1992
AEGIS THERAPEUTICS INC32008–2018
HALE BIOPHARMA VENTURES LLC32013–2017
Locations
LocationPatentsSpan
San Diego, California, US401983–2020
Redwood City, California, US61980–1983